Clinical Conversations: The Data for JAK Inhibitors in AD
Tolerability of JAK Inhibitors Used in Dermatology
Matthew J. Zirwas, MD
Adelaide Hebert, MD
Clinical Conversations: Risks vs Benefits of JAK Inhibitors
Clinical Conversations: MOA of JAK Inhibitors in Dermatology
Brad Glick, DO, MPH
Raj Chovatiya, MD, PhD
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.